AACI publishes report on staff retention at clinical trials offices

Cancer History Project Conversation with The Cancer Letter

2024 Karnofsky Award winner Lillian Siu talks about her career in phase I studies, ctDNA, and her mentor’s “evil red pencil”

Lillian L. Siu discovered her passion while perusing employment ads in the Journal of Clinical Oncology.

May 10, 2024

FDA issues additional draft guidance on eligibility criteria for cancer drug clinical trials

FDA issued three draft guidance documents on eligibility criteria in cancer clinical trials to address performance status, washout periods and concomitant medications, and laboratory values.

May 03, 2024

Vol.50 No.18

Drugs & Targets

COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI

COTA, a leader in real-world data and analytics for oncology, is entering a collaboration with Sanofi to use RWD and artificial intelligence to increase the speed of oncology trials, including for multiple myeloma.

April 19, 2024

Vol.50 No.16

Clinical Roundup

One in five people with cancer participate in medical research studies, Fred Hutchinson study shows

Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network, and peer institutions released findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer, or 21.9%, participate in some form of clinical research.

April 05, 2024

Vol.50 No.14

Regulatory News

Exercising new powers, FDA issues Complete Response Letters based on insufficient enrollment in confirmatory trials

FDA issued Complete Response Letters for the Biologics License Application for odronextamab in relapsed/refractory follicular lymphoma and in R/R diffuse large B-cell lymphoma, each after two or more lines of systemic therapy.

Etta Pisano named senior portfolio lead at ARPA-H

Etta D. Pisano was named senior portfolio lead at the Advanced Research Projects Agency for Health.

March 29, 2024

Vol.50 No.13

AACI publishes report on staff retention at clinical trials offices

YOU MAY BE INTERESTED IN

2024 Karnofsky Award winner Lillian Siu talks about her career in phase I studies, ctDNA, and her mentor’s “evil red pencil”

FDA issues additional draft guidance on eligibility criteria for cancer drug clinical trials

COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI

One in five people with cancer participate in medical research studies, Fred Hutchinson study shows

Exercising new powers, FDA issues Complete Response Letters based on insufficient enrollment in confirmatory trials

Etta Pisano named senior portfolio lead at ARPA-H

Renew today!

Subscriber content

Login